Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence | Zendy

Manjiree Karandikar | Zendy; Carly E. Milliren | Zendy; Robin Zaboulian | Zendy; Poornima Peiris | Zendy; Tanvi Sharma | Zendy; Andrew E. Place | Zendy; Thomas J. Sandora | Zendy

Open Access

Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence

Author(s) -

Manjiree Karandikar,

Carly E. Milliren,

Robin Zaboulian,

Poornima Peiris,

Tanvi Sharma,

Andrew E. Place,

Thomas J. Sandora

Publication year - 2019

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piz064

Subject(s) - medicine , febrile neutropenia , vancomycin , vancomycin resistant enterococcus , incidence (geometry) , neutropenia , limiting , enterococcus , gram positive bacterial infections , intensive care medicine , oncology , antibiotics , chemotherapy , microbiology and biotechnology , staphylococcus aureus , physics , biology , bacteria , mechanical engineering , engineering , optics , genetics

Limited data exists regarding the effects of empiric antibiotic use in pediatric oncology patients with febrile neutropenia (FN) on the development of antibiotic resistance. We evaluated the impact of a change in our empiric FN guideline limiting vancomycin exposure on the development of vancomycin-resistant Enterococcus in pediatric oncology patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research